The available studies differ in drug type, dose, indication, timing of exposure, comparator structure, and baseline maternal metabolic risk, and the number of exposed pregnancies remains insufficient to exclude uncommon but clinically important harms ( 4.5.3 Risk communication: clarifying uncertainty Current evidence is insufficient to classify GLP-1RAs as relatively safe during pregnancy, and they should certainly not be used as a first-line treatment for gestational obesity or diabetes simply due to their weight-loss benefits ( 4.6 Quality of life and psychology: benefits driven by symptom and weight improvement Quality of life (QoL) impairment in PCOS is frequently linked to weight distress, hirsutism, and infertility-related anxiety
The use of miR-15a mimic or siGPX4 can promote the death of prostate cancer cells [34]
Combining skin tightening with other treatments can address multiple concerns simultaneously and enhance overall outcomes
Amazon $AMZN is launching a GLP-1 management program through its primary care arm, One Medical, that integrates obesity treatment into routine care and pairs it with fulfillment through Amazon Pharmacy
This is why Canadas 2025 obesity guidelines and most clinicians treat them as first-line for many patients seeking weight loss treatment
